Found to be homozygously deleted at high frequency in cell lines derived from tumors of lung, breast, brain, bone, skin, bladder, kidney, ovary, and lymphocyte. Mutations are also associated with pancreatic adenocarcinoma.
Immunogen
CDKN2A antibody was raised against human p16 protein (missing the first 7 amino acids).
Key Feature
Clonality
Polyclonal
Host Species
Rabbit
Tested Applications
ELISAIFIHCIPWB
CDKN2A antibody can be used in ELISA, and immunohistochemistry starting at 10 μg/mL.: